MENU

IGC IGC Pharma Forecast, Technical & Fundamental Analysis

a company, which engages in focuses on developing and commercializing a portfolio of cannabinoid based biopharmaceutical therapies

Industry Biotechnology
IGC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
IGC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IGC is expected to report earnings to rise 50.00% to -2 cents per share on February 12

IGC Pharma IGC Stock Earnings Reports
Q4'24
Est.
$-0.03
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.01
Q1'24
Est.
$-0.04
Q4'23
Missed
by $0.05
The last earnings report on November 14 showed earnings per share of -1 cents, beating the estimate of -2 cents. With 70.27K shares outstanding, the current market capitalization sits at 27.06M.
A.I. Advisor
published General Information

General Information

a company, which engages in focuses on developing and commercializing a portfolio of cannabinoid based biopharmaceutical therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
10224 Falls Road
Phone
+1 301 983-0998
Employees
61
Web
https://www.igcinc.us
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

IGC and Stocks

Correlation & Price change

A.I.dvisor tells us that IGC and CRNX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IGC and CRNX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGC
1D Price
Change %
IGC100%
-2.59%
CRNX - IGC
28%
Poorly correlated
+1.26%
VNDA - IGC
27%
Poorly correlated
-6.59%
CSCI - IGC
24%
Poorly correlated
-3.40%
ATNM - IGC
23%
Poorly correlated
-3.51%
ATBPF - IGC
22%
Poorly correlated
N/A
More